Biomedical Engineering Reference
In-Depth Information
24. Sahoo S, Toh SL, Goh JCH (2010) A bFGF-releasing silk/PLGA-based biohybrid scaffold for
ligament/tendon
tissue
engineering
using
mesenchymal
progenitor
cells.
Biomaterials
31:2990-2998
25. Venkatesh S, Sizemore SP, Byrne ME (2007) Biomimetic hydrogels for enhanced loading
and extended release of ocular therapeutics. Biomaterials 28:717-724
26. Petka WA, Harden JL, McGrath KP, Wirtz D, Tirrell DA (1998) Reversible hydrogels from
self-assembling artificial proteins. Science 281:389-392
27. Luo G, Zhang Q, Del Castillo AR, Urban V, O'Neill H (2009) Characterization of sol-gel-
encapsulated proteins using small-angle neutron scattering. ACS Appl Mater Interfaces
1:2262-2268
28. Lysaght MJ, Reyes J (2001) The growth of tissue engineering. Tissue Eng 7:485-493
29. Huebner EA, Strittmatter SM (2009) Axon regeneration in the peripheral and central nervous
systems. Results Probl Cell Differ 48:339-351
30. Galvan V, Jin K (2007) Neurogenesis in the aging brain. Clin Interv Aging 2:605-610
31. Jin K, Galvan V (2007) Endogenous neural stem cells in the adult brain. J Neuroimmune
Pharmacol 2:236-242
32. Stieglitz T (2009) Development of a micromachined epiretinal vision prosthesis. J Neural
Eng 6:065005
33. Freudenberg U, Hermann A, Welzel PB, Stirl K, Schwarz SC, Grimmer M, Zieris A,
Panyanuwat W, Zschoche S, Meinhold D, Storch A, Werner C (2009) A star-PEG-heparin
hydrogel
platform
to
aid
cell
replacement
therapies
for
neurodegenerative
diseases.
Biomaterials 30:5049-5060
34. Kettenmann H, Ransom BR (1995) Neuroglia. Oxford University Press, New York
35. Saito A, Sawada K, Fujimura S (2011) Present status and future perspectives on the
development of bioartificial kidneys for the treatment of acute and chronic renal failure
patients. Hemodial Int 15:183-192
36. Ye SH, Watanabe J, Takai M, Iwasaki Y, Ishihara K (2005) Design of functional hollow fiber
membranes modified with phospholipid polymers for application in total hemopurification
system. Biomaterials 26:5032-5041
37. Ding F, Humes HD (2008) The bioartificial kidney and bioengineered membranes in acute
kidney injury. Nephron Exp Nephrol 109:e118-e122
38. Rozga J, Malkowski P (2010) Artificial liver support: quo vadis? Ann Transplant 15:92-101
39. Gonez LJ, Knight KR (2010) Cell therapy for diabetes: stem cells, progenitors or beta-cell
replication? Mol Cell Endocrinol 323:55-61
40. Sumi S (2010) Regenerative medicine for insulin deficiency: creation of pancreatic islets and
bioartificial pancreas. J Hepatobiliary Pancreat Sci 18:6-12
41. Niebruegge S, Nehring A, Bar H, Schroeder M, Zweigerdt R, Lehmann J (2008)
Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source
for great amounts of functional cardiomyocytes. Tissue Eng Part A 14:1591-1601
42. Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473:326-335
43. Rodriguez-Granillo A, Rubilar B, Rodriguez-Granillo G, Rodriguez AE (2011) Advantages
and disadvantages of biodegradable platforms in drug eluting stents. World J Cardiol 3:84-92
44. Lei L, Guo SR, Chen WL, Rong HJ, Lu F (2011) Stents as a platform for drug delivery.
Expert Opin Drug Deliv 8:813-831
45. Hanjaya-Putra D, Gerecht S (2009) Vascular engineering using human embryonic stem cells.
Biotechnol Prog 25:2-9
46. Ravi S, Chaikof EL (2010) Biomaterials for vascular tissue engineering. Regen Med
5:107-120
47. Avila G, Misch K, Galindo-Moreno P, Wang HL (2009) Implant surface treatment using
biomimetic agents. Implant Dent 18:17-26
48. Zilberman M, Kraitzer A, Grinberg O, Elsner JJ (2010) Drug-eluting medical implants.
Handb Exp Pharmacol 199:299-341
49. Shekaran A, Garcia AJ (2011) Extracellular matrix-mimetic adhesive biomaterials for bone
repair. J Biomed Mater Res A 96:261-272
Search WWH ::
Custom Search